zanamivir has been researched along with ribavirin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (17.65) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 19 (55.88) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, KW; Barnard, DL; Day, CW; Furuta, Y; Morrey, JD; Sidwell, RW; Smee, DF; Wong, MH | 1 |
| Li, YH; Li, ZR; Liu, ZY; Shao, HY; Wang, B; Yi, H; You, XF; Zhao, LX | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Batta, G; Bereczki, I; Borbás, A; Fejes, Z; Herczegh, P; Kiss-Szikszai, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Török, Z | 1 |
| Cesur, N; Cesur, Z; Göktaş, F; Naesens, L; Vanderlinden, E | 1 |
| Batta, G; Bereczki, I; Borbás, A; Herczegh, P; Jóna, I; Kéki, S; Máté, G; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Vanderlinden, E | 1 |
| Gao, H; Gu, Q; Guo, W; Li, D; Wang, Q; Wang, W; Zhang, L; Zhu, M; Zhu, T | 1 |
| Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S | 1 |
| Batta, G; Bereczki, I; Borbás, A; Dobray, L; Herczegh, P; Kéki, S; Kicsák, M; Naesens, L; Nikodém, ÉN; Ostorházi, E; Rozgonyi, F; Vanderlinden, E | 1 |
| Cichero, E; Costi, MP; Gazzarrini, S; Loddo, R; Moroni, A; Naesens, L; Santucci, M; Tasso, B; Tonelli, M | 1 |
| Barniol-Xicota, M; Caffrey, M; Codony, S; Ginex, T; Leiva, R; Luque, FJ; Montes, M; Naesens, L; Vanderlinden, E; Vázquez, S | 1 |
| Cichero, E; Costi, MP; Francesconi, V; Giordanetto, F; Giovannini, L; Naesens, L; Santucci, M; Tonelli, M | 1 |
| Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E | 1 |
| Bertagnin, C; Ding, X; Fang, Z; Gao, P; Huang, B; Jia, H; Jia, R; Kang, D; Kong, X; Liu, X; Loregian, A; Ma, X; Murugan, NA; Poongavanam, V; Sun, Z; Tian, Y; Xu, W; Zhan, P; Zhang, J | 1 |
| Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V | 1 |
| Ai, W; Cherukupalli, S; Ding, X; Huang, B; Jia, R; Jiang, X; Li, Z; Liu, X; Ma, X; Sun, L; Sun, Z; Wang, D; Zalloum, WA; Zhan, P; Zhang, J | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dempsey, MH; Penn, CR; Ryan, DM; Ticehurst, J | 1 |
| Hayden, FG; Madren, LK; Rollins, BS | 1 |
| Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH | 1 |
| Mossad, SB | 1 |
| Keating, MR | 1 |
| Lynch, JP; Walsh, EE | 1 |
| Ariano, RE; Smith, JR; Toovey, S | 1 |
| Razonable, RR | 1 |
| Cen, S; He, Z; Li, XY; Liu, ZL; Wang, X; Wang, Z; Wei, XL; Yin, X; Zhang, ZZ; Zhou, JM | 1 |
| Chung, HK; Lamb, K; Lin, MZ; Plemper, RK; Weisshaar, M; Yan, D | 1 |
| Hussain, M; Jin, R; Li, M; Li, X; Lin, C; Liu, X; Sun, C; Tu, Z; Wan, J; Zhang, J; Zhou, Y | 1 |
| Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
| Emmott, E; Goodfellow, I; Jalal, H; Smielewska, A | 1 |
| Abed, Y; Baz, M; Boivin, G; Checkmahomed, L; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O | 1 |
6 review(s) available for zanamivir and ribavirin
| Article | Year |
|---|---|
Underused options for preventing and treating influenza.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir | 1999 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Influenza: evolving strategies in treatment and prevention.
Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir | 2007 |
The use of antiviral agents for the management of severe influenza.
Topics: Age Factors; Antiviral Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferons; Length of Stay; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Risk Factors; Viral Load; Zanamivir | 2010 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
28 other study(ies) available for zanamivir and ribavirin
| Article | Year |
|---|---|
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Topics: Amides; Animals; Antiviral Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung; Mice; Mice, Inbred BALB C; Oseltamivir; Oxygen; Pyrazines; Survival Analysis; Virus Replication | 2007 |
Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
Topics: Administration, Oral; Animals; Cell Line; Disease Models, Animal; Dogs; Drug Design; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Infusions, Parenteral; Inhibitory Concentration 50; Mice; Ribavirin; Zanamivir | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Drug Resistance, Viral; Gram-Positive Bacteria; Herpesvirus 1, Human; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Isoindoles; Microbial Sensitivity Tests; o-Phthalaldehyde; Teicoplanin | 2012 |
Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Topics: Adamantane; Amides; Animals; Antiviral Agents; Aza Compounds; Chickens; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Microwaves; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Virus Replication | 2012 |
Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.
Topics: Anti-Bacterial Agents; Antiviral Agents; Dose-Response Relationship, Drug; Doxorubicin; Fluorescence; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Orthomyxoviridae; Structure-Activity Relationship | 2012 |
Aspulvinones from a mangrove rhizosphere soil-derived fungus Aspergillus terreus Gwq-48 with anti-influenza A viral (H1N1) activity.
Topics: 4-Butyrolactone; Animals; Antiviral Agents; Aspergillus; Benzylidene Compounds; Binding Sites; Catalytic Domain; Cell Line; Cell Survival; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Docking Simulation; Neuraminidase; Rhizosphere; Soil Microbiology | 2013 |
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.
Topics: | 2012 |
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Topics: Animals; Antiviral Agents; Binding Sites; Dogs; Dose-Response Relationship, Drug; Lipid Bilayers; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Structure-Activity Relationship; Teicoplanin | 2014 |
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
Topics: Antiviral Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proguanil; Respiratory Syncytial Viruses; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2017 |
Aniline-Based Inhibitors of Influenza H1N1 Virus Acting on Hemagglutinin-Mediated Fusion.
Topics: Aniline Compounds; Binding Sites; HeLa Cells; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Conformation; Virus Internalization | 2018 |
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Topics: Antiviral Agents; Aza Compounds; Dose-Response Relationship, Drug; Folic Acid Antagonists; Models, Molecular; Molecular Structure; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2018 |
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin | 2018 |
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
Topics: Animals; Antiviral Agents; Catalytic Domain; Dogs; Drug Design; Drug Resistance, Viral; Drug Stability; Humans; Influenza A virus; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Mutation; Neuraminidase; Nitrogen; Oseltamivir; Rats; Tissue Distribution | 2018 |
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses | 2019 |
Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Topics: Animals; Antiviral Agents; Chickens; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Female; Influenza A virus; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Neuraminidase; Oseltamivir; Structure-Activity Relationship | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).
Topics: Amantadine; Animals; Antiviral Agents; Guanidines; Influenza A virus; Influenza B virus; Mice; Neuraminidase; Orthomyxoviridae Infections; Pyrans; Ribavirin; Sialic Acids; Virus Replication; Zanamivir | 1994 |
Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium.
Topics: Animals; Antiviral Agents; Cell Line; Dogs; Epithelium; Guanidines; Humans; Influenza A virus; Influenza B virus; Kidney; Neuraminidase; Organ Culture Techniques; Pyrans; Respiratory System; Ribavirin; Rimantadine; Sialic Acids; Virus Replication; Zanamivir | 1994 |
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir | 1998 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir | 1999 |
[Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase].
Topics: Alphainfluenzavirus; Amantadine; Antiviral Agents; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Luciferases; Oseltamivir; Plasmids; Reproducibility of Results; Ribavirin; RNA-Dependent RNA Polymerase; Sensitivity and Specificity; Transfection; Zanamivir | 2012 |
Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
Topics: Animals; Antiviral Agents; Benzylidene Compounds; Cell Line; Coinfection; Dogs; Dose-Response Relationship, Drug; Feasibility Studies; Fenretinide; Genes, Reporter; High-Throughput Screening Assays; Humans; Influenza A virus; Luciferases, Firefly; Luciferases, Renilla; Naltrexone; Narcotic Antagonists; Neuraminidase; Respiratory Syncytial Viruses; Ribavirin; Virus Internalization; Virus Replication; Zanamivir | 2015 |
Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
Topics: Antiviral Agents; Drug Discovery; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Microbial Sensitivity Tests; Oseltamivir; Purine Nucleosides; Ribavirin; Zanamivir | 2016 |
In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir.
Topics: Amides; Antiviral Agents; Cell Line, Tumor; Cytopathogenic Effect, Viral; Humans; Parainfluenza Virus 3, Human; Pyrazines; Respirovirus Infections; Ribavirin; Virus Attachment; Virus Replication; Zanamivir | 2018 |
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
Topics: Acids, Carbocyclic; Amides; Animals; Antiviral Agents; Cell Line; Dibenzothiepins; Dogs; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Guanidines; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Madin Darby Canine Kidney Cells; Morpholines; Neuraminidase; Nucleic Acid Synthesis Inhibitors; Orthomyxoviridae Infections; Oseltamivir; Pyrazines; Pyridones; Ribavirin; Triazines; Viral Proteins; Virus Replication; Zanamivir | 2020 |